Title:
METHOD OF TARGETING A THERAPEUTIC AGENT
Document Type and Number:
WIPO Patent Application WO2005019166
Kind Code:
A3
Abstract:
Disclosed are conjugates in which an aminoadamantane derivative, such as amantadine, memantine, or rimantadine is linked to a therapeutic agent. The conjugate can then be used to target the therapeutic agent to an injured neuron.
Inventors:
WENT GREGORY T (US)
WASLEY JAN W F (US)
LIPTON STUART A (US)
LARRICK JAMES W (US)
MEYERSON LAURENCE R (US)
STAMLER JONATHAN S (US)
WASLEY JAN W F (US)
LIPTON STUART A (US)
LARRICK JAMES W (US)
MEYERSON LAURENCE R (US)
STAMLER JONATHAN S (US)
Application Number:
PCT/US2004/019045
Publication Date:
September 14, 2006
Filing Date:
June 14, 2004
Export Citation:
Assignee:
NEUROMOLECULAR INC (US)
WENT GREGORY T (US)
WASLEY JAN W F (US)
LIPTON STUART A (US)
LARRICK JAMES W (US)
MEYERSON LAURENCE R (US)
STAMLER JONATHAN S (US)
WENT GREGORY T (US)
WASLEY JAN W F (US)
LIPTON STUART A (US)
LARRICK JAMES W (US)
MEYERSON LAURENCE R (US)
STAMLER JONATHAN S (US)
International Classes:
A61K31/445; A61K31/13; A61K31/40; C07D
Foreign References:
| US6384083B1 | 2002-05-07 | |||
| US20030008889A1 | 2003-01-09 |
Other References:
See also references of EP 1638931A4
Download PDF:
Previous Patent: PREPARATION OF PHENETHANOLAMINE DERIVATIVES
Next Patent: MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST
Next Patent: MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST